Top Markets
Coin of the day
Kolon TissueGene, Inc. Kolon TissueGene, Inc.

Kolon TissueGene, Inc.

950160
Classement en actions #9085
Kolon TissueGene, Inc. is a biopharmaceutical firm specializing in the... Kolon TissueGene, Inc. is a biopharmaceutical firm specializing in the advancement of clinical-stage cell-based treatments for osteoarthritis. Its flagship offering is TG-C, a proprietary platform technology that integrates allogeneic primary cells with genetically engineered counterparts. Established by Kwan H. Lee on June 9, 1999, the enterprise maintains its corporate headquarters in Rockville, Maryland.
Prix de l'action
$12.94
Dernière synchronisation: 2026-08-28
Capitalisation boursière
$1.10B
Changement (1 jour)
-0.16%
Changement (1 an)
-51.50%
Pays
US
Échange Kolon TissueGene, Inc. (950160)

Catégorie

Historique du prix de l'action pour Kolon TissueGene, Inc. (950160)
Prix de clôture le plus élevé : $14.96 le 2026-08-01

Prix de clôture le plus bas : $50.89 le 2017-11-01
Historique du prix de l'action de Kolon TissueGene, Inc. de 2017 à 2026
Performance annuelle du prix de l'action
Année Performance
2026 (TTM) -2.28%
2025 232.88%
2024 144.93%
2023 -18.79%
2022 -12.44%
2019 -73.89%
2018 -22.36%
2017 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
$542.09 38.63%
US
$1.03K 44.13%
NL
$121.53 -12.70%
AU
$138.18 473.58%
US
$759.27 7.20%
CH